Epizyme and Celgene extend cancer therapy research collaboration
9 July 2015 | By Victoria White
Epizyme has amended and restated its agreement with Celgene to extend their research collaboration for at least three additional years...
List view / Grid view
9 July 2015 | By Victoria White
Epizyme has amended and restated its agreement with Celgene to extend their research collaboration for at least three additional years...
9 July 2015 | By Victoria White
Scientists have shown that didehydro-Cortistatin A reduces residual levels of HIV virus from dormant cells, establishing a near-permanent state of latency...
8 July 2015 | By Victoria White
Pfizer’s Centres for Therapeutic Innovation and the Jeffrey Modell Foundation are to collaborate to conduct research in the field of immunological diseases...
8 July 2015 | By Oxford Global
Oxford Global Conferences are proud to present the Cell & Gene Therapy with our co-located 2nd Annual Stem Cell Congress is taking place on the 9th & 10th of November in London, UK...
7 July 2015 | By Oxford Global
The 2nd Annual Drug Discovery USA Congress is taking place on the 29th & 30th of October 2015 in Boston, USA...
7 July 2015 | By Victoria White
FY26, a drug able to shut down a cancer cell by exploiting weaknesses inherent in their energy generation, is 49 times more potent than Cisplatin...
6 July 2015 | By Victoria White
Scientists at the have discovered that a common drug given to arthritis sufferers, Methotrexate, could also help to treat patients with blood cancers...
6 July 2015 | By Oxford Global
Oxford Global Conferences are delighted to announce the 2nd Annual Stem Cell Congress with our co-located Cell & Gene Therapy is taking place on the 9th & 10th of November in London, UK..
3 July 2015 | By Victoria White
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective flu vaccines...
1 July 2015 | By Victoria White
Scientists have discovered a new protein which triggers the growth of blood vessels in breast cancer tumours which have spread to the brain...
30 June 2015 | By Victoria White
Scientists have unravelled a key process in the bacterium that causes TB, potentially paving the way for new antibiotics to fight the disease...
30 June 2015 | By Cisbio Bioassays & Trevena, Inc.
TRV027 is a biased ligand; the in vitro profile and its translation into in vivo pharmacology is discussed during this webinar.
26 June 2015 | By Victoria White
Siemens and BioNTech will work together on the construction of a fully automated and digitalised production site for BioNTech's personalised cancer vaccines...
26 June 2015 | By Victoria White
Invenra and Oxford BioTherapeutics are to collaborate to identify and characterise a panel of fully human therapeutic mAbs against a novel cancer target...
25 June 2015 | By Victoria White
Scientists from University College London have designed a chemical compound that has reduced the growth of pancreatic cancer tumours by 80% in treated mice...